MDxHealth (MDXH) Short term Debt (2020 - 2026)

MDxHealth has disclosed Short term Debt across 7 years of filings, most recently posting $95.9 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $95.9 million, up 27.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.9 million (up 27.31% YoY), and the FY2025 annual result was $76.2 million, up 23417.59% from the prior year.
• Short term Debt came in at $95.9 million for Q1 2026 at MDxHealth, up from $76.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $75.7 billion in Q2 2025 to a low of $324000.0 in Q4 2024.
• The 5-year median for Short term Debt is $35.8 million (2024), against an average of $5.1 billion.
• Across the five-year window, Short term Debt tumbled 98.16% in 2023 and jumped 147341.14% in 2025, its largest moves.
• MDxHealth's Short term Debt stood at $34.9 million in 2022, then sank by 98.16% to $643000.0 in 2023, then tumbled by 49.61% to $324000.0 in 2024, then jumped by 23417.59% to $76.2 million in 2025, then increased by 25.92% to $95.9 million in 2026.
• The last three Short term Debt figures came in at $95.9 million (Q1 2026), $76.2 million (Q4 2025), and $75.9 million (Q3 2025), per Business Quant data.